Secukinumab B

Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatment of moderate to severe plaque psoriasis.

Product Specifications

CAS Number

1229022-83-6

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

IL Receptor

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP2-47672R 0.1 mL

Mouse Monoclonal HLA DRB1 Antibody (LN-3 + HLA-DRB/1067) [DyLight 550]

Ask

View Details

A10023-50UG 50 µg

T7-Tag Monoclonal Antibody

Ask

View Details

NBP3-27020AF647 0.1 mL

Mouse Monoclonal TRPC6 Antibody (TRPC6/7671) [Alexa Fluor 647]

Ask

View Details

037300 200 µL

KCNB2, NT (KCNB2, Potassium voltage-gated channel subfamily B member 2, Voltage-gated potassium channel subunit Kv2.2)

Ask

View Details

NBP3-18253UV 0.1 mL

Rabbit Polyclonal Beclin 2 Antibody [DyLight 350]

Ask

View Details

A76276-100UL 100 µL

CYP1A2 Antibody

Ask

View Details